Author

A. Ullrich

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:mouse· 3 Approach:experimental assay· 2 Assay:proteomics· 2 Approach:statistical model· 2 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

H. M. Gibson· 2 shared A. A. Inoue· 1 shared A. Allikalt· 1 shared A. Basbaum· 1 shared B. Bottcher· 1 shared B. K. Shoichet· 1 shared C. Turro· 1 shared D. Weikert· 1 shared

Activity by Year

2023-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

H. M. Gibson

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Ru(II)-Photoactive Agents for Targeting ER Stress and Immunogenic Cell Death

M. Denison, A. Ullrich, M. Herroon, S. Mecca, C. Turro, I. PODGORSKI, H. M. Gibson, J. J. Kodanko

This paper evaluates two Ru(II) photoactive agents, showing compound 2 induces ER stress and immunogenic cell death in cancer cells and elicits anti-tumor immunity in vivo.

bioRxiv · Jul 18, 2024 · PreprintCancer Biology

Discovery of a functionally selective serotonin 5-HT1A receptor agonist for the treatment of pain

A. Ullrich, J. Schneider, J. M. Braz, E. Neu, N. Staffen, M. Stanek, J. Blahova, T. Hove, T. Albert, A. Allikalt, S. Lober, K. Bhardwaj, S. Rodriguez-Rosado, E. A. Fink, T. Rasmussen, , P. Gmeiner

The paper identifies ST171, a selective 5-HT1A receptor agonist effective in pain models without sedation, and elucidates its mechanism through structural and computational analysis.

bioRxiv · Sep 11, 2023 · PreprintPharmacology & Toxicology

Host genetic background regulates the capacity for anti-tumor antibody-dependent phagocytosis

J. E. Glassbrook, J. B. Hackett, M. C. Muniz, M. Bross, G. Dyson, N. Movahhedin, A. Ullrich, H. M. Gibson

This study shows host genetics influence anti-tumor antibody therapy effectiveness by affecting macrophage phagocytosis capacity in mouse models.

bioRxiv · May 9, 2023 · PreprintCancer Biology